Research Areas

Pharmacokinetics of Insulin Lispro to Investigate Novel Insulin on Board Calculations

Two Treatment Approaches for An Approved Insulin (Thrice-Daily versus Twice-Daily) in Subjects with Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy with or without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial

A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of An Investigational Medication in Subjects with Type 2 Diabetes Mellitus

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of An Implanted Device That Administers an Approved Diabetes Medication in Patients with Type 2 Diabetes

A Double-Blind, Placebo Controlled, Phase 2 Study to Assess the Safety, Tolerability and Efficacy of An Investigational Medication Administered Once Weekly By Subcutaneous Injection to Patients With Type 2 Diabetes Mellitus Being Treated with Metformin

A Trial Comparing the Efficacy and Safety of An Investigational Insulin Combination Versus Insulin Glargine in Subjects with Type 2 Diabetes Mellitus

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Blood Pressure Reduction with Ambulatory Blood Pressure Monitoring (ABPM), Safety, and Tolerability of An Approved Diabetes Medication in Treatment of Subjects with Hypertension and Type 2 Diabetes Mellitus

A Randomized, Double Blind, Cross-Over Trial Comparing the Safety and Efficacy of An Investigational Insulin and Insulin Glargine Both in Combination with Metformin in Subjects with Type 2 Diabetes.

A Phase 1, Randomized, Double-blind, Placebo Controlled Parallel-Group Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of An Investigational Medication in Subjects with Type 2 Diabetes Mellitus and Moderate to Severe Renal Impairment

A Phase II, 12-Week, Double-Blind, Randomised, Parallel Group, Multi-Centre, International Trial to Assess the Effect on Glycaemic Control of Five Doses of An Investigational Medication Versus Placebo or Open-Label Liraglutide in Subjects with Type 2 Diabetes.

A Phase 3, Randomized, Active Comparator, Double-Blind, Multi-Center study to Compare the Efficacy, Safety, and Tolerability of An Investigational Medication to Sitagliptin as Add-on Therapy to Metformin in Patients with Type 2 Diabetes.

Efficacy and Safety of An Investigational Medication Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-Naïve Subjects with Type 2 Diabetes.

Evaluation of Metabolic Outcomes and Safety of An Investigational Compound Used as a Pre-Administration Infusion Site Treatment in Subjects with Type 1 Diabetes (T1DM) Using Continuous Subcutaneous Insulin Infusion (CSII)

Efficacy and Safety of An Investigational Insulin Compared to Insulin Aspart Both in Combination with Insulin Detemir in Adults with Type 1 Diabetes

A Phase III Clinical Trial to Study the Safety and Efficacy of An Investigational Insulin Compared to Lantus in Subjects With Type 1 Diabetes Mellitus

A Randomized, Double Blind, Cross-Over Trial Comparing the Safety and Efficacy of An Investigational Insulin and Insulin Glargine, Both with Insulin Aspart as Mealtime Insulin in Subjects with Type 1 Diabetes.

The Efficacy and Safety of An Approved Diabetes Medication Adjunct to Insulin Treatment in Type 1 Diabetes. A 26-Week Randomized, Insulin Capped, Placebo-Controlled, Double-Blind, Parallel Group, Multinational, Multicenter Trial.

An Open-Label, Randomized, Multicenter, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of An Investigational Insulin Glargine with Lantus in Type 1 Diabetes Mellitus Patients.

A 20-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial to Assess the Safety and Efficacy of An Investigational Medication on Body Weight in Obese Subjects Without Diabetes.

A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of An Investigational Topical Gel in the Treatment of Pain Associated with Painful Diabetic Neuropathy.